VERTEX PHARMACEUTICALS
About
Job Description
Research Scientist, Computational Drug Design
General Summary
We are seeking a highly motivated and experienced computational chemist to join our Computational Drug Design group in Boston. This individual will be responsible for contributing to both hit/lead identification and optimization programs using methods encompassing all computational aspects of drug discovery. The right candidate's responsibilities include close interaction with interdisciplinary projects teams to ide...
Updates & Highlights
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Mixed Recent Returns And Long Term Shareholder Gains
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Mixed Recent Returns And Long Term Shareholder Gains
Yahoo Finance · 36 minutes ago
Vertex Pharmaceuticals (VRTX) Reveals Promising Cystic Fibrosis Treatment Data
Vertex Pharmaceuticals (VRTX) Reveals Promising Cystic Fibrosis Treatment Data
GuruFocus · about 16 hours ago
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Gains And Renal Trial Progress
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Gains And Renal Trial Progress
simplywall.st · about 16 hours ago
Recent Openings
View all 3 jobsAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Competitive Salary
Market-rate compensation
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Vertex Pharmaceuticals?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentAssessing Vertex Pharmaceuticals (VRTX) Valuation After Mixed Recent Returns And Long Term Shareholder Gains
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Mixed Recent Returns And Long Term Shareholder Gains
Yahoo Finance · 36 minutes ago
Vertex Pharmaceuticals (VRTX) Reveals Promising Cystic Fibrosis Treatment Data
Vertex Pharmaceuticals (VRTX) Reveals Promising Cystic Fibrosis Treatment Data
GuruFocus · about 16 hours ago
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Gains And Renal Trial Progress
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Gains And Renal Trial Progress
simplywall.st · about 16 hours ago
Ixlayer rolls out digital acute pain management platform in collaboration with Vertex Pharmaceuticals
Ixlayer rolls out digital acute pain management platform in collaboration with Vertex Pharmaceuticals
Fierce Healthcare · about 22 hours ago
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains
MarketWatch · 1 day ago
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Liu Joy
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Liu Joy
Moomoo · 2 days ago
Insider Sell: Joy Liu Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
Insider Sell: Joy Liu Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus · 2 days ago
Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus · 3 days ago
Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus · 3 days ago
Is Vertex Pharmaceuticals (VRTX) Offering An Opportunity After Recent Share Price Consolidation?
Is Vertex Pharmaceuticals (VRTX) Offering An Opportunity After Recent Share Price Consolidation?
Yahoo Finance · 3 days ago
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
MarketWatch · 4 days ago
Vertex Pharmaceuticals Inc Stock (VRTX) Closed Down by 3.03% on Jun 2: Facts Behind the Movement
Vertex Pharmaceuticals Inc Stock (VRTX) Closed Down by 3.03% on Jun 2: Facts Behind the Movement
tradingkey.com · 4 days ago
Vertex Pharmaceuticals Insider Sold Shares Worth $888,300, According to a Recent SEC Filing
Vertex Pharmaceuticals Insider Sold Shares Worth $888,300, According to a Recent SEC Filing
marketscreener.com · 4 days ago
Vertex Pharmaceuticals offers a strong long-term buy with its cystic fibrosis monopoly and robust cash flow.
Vertex Pharmaceuticals offers a strong long-term buy with its cystic fibrosis monopoly and robust cash flow.
Pluang · 4 days ago
Should FDA’s IgA Nephropathy BLA Acceptance for Povetacicept Reshape Vertex Pharmaceuticals’ (VRTX) Investment Narrative?
Should FDA’s IgA Nephropathy BLA Acceptance for Povetacicept Reshape Vertex Pharmaceuticals’ (VRTX) Investment Narrative?
Yahoo Finance · 4 days ago
Does Health Canada’s Review Of Suzetrigine Reshape The Bull Case For Vertex Pharmaceuticals (VRTX)?
Does Health Canada’s Review Of Suzetrigine Reshape The Bull Case For Vertex Pharmaceuticals (VRTX)?
simplywall.st · 4 days ago
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
MarketWatch · 5 days ago
Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?
Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?
Yahoo Finance · 5 days ago
Vertex Pharmaceuticals (VRTX) Receives FDA BLA Acceptance for Po
Vertex Pharmaceuticals (VRTX) Receives FDA BLA Acceptance for Po
GuruFocus · 5 days ago
Vertex Pharmaceuticals (VRTX) Receives FDA BLA Acceptance for Po
Vertex Pharmaceuticals (VRTX) Receives FDA BLA Acceptance for Po
GuruFocus · 5 days ago